{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T16:27:13Z","timestamp":1781108833222,"version":"3.54.1"},"reference-count":166,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.phrs.2025.108059","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T16:11:12Z","timestamp":1765037472000},"page":"108059","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["From the gut to the brain: Potential novel avenues for IBD treatment via serotonergic pathways"],"prefix":"10.1016","volume":"222","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-5111-7136","authenticated-orcid":false,"given":"Sara","family":"Ibgui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisy","family":"Lints","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4384-5516","authenticated-orcid":false,"given":"Simon","family":"Milling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2025.108059_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2468-1253(19)30333-4","article-title":"The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"5","author":"Alatab","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.phrs.2025.108059_bib2","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1365-2036.2010.04234.x","article-title":"Systematic review: the costs of ulcerative colitis in Western countries","volume":"31","author":"Cohen","year":"2010","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2025.108059_bib3","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/flgastro-2014-100514","article-title":"A UK cost of care model for inflammatory bowel disease","volume":"6","author":"Ghosh","year":"2015","journal-title":"Frontline Gastroenterol."},{"key":"10.1016\/j.phrs.2025.108059_bib4","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.cgh.2016.11.027","article-title":"Predicting Costs of Care for Patients With Inflammatory Bowel","volume":"15","author":"Click","year":"2017","journal-title":"Dis. Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.phrs.2025.108059_bib5","series-title":"StatPearls","article-title":"Inflammatory Bowel Disease","author":"McDowell","year":"2024"},{"key":"10.1016\/j.phrs.2025.108059_bib6","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/ecco-jcc\/jjy113","article-title":"ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications","volume":"13","author":"Maaser","year":"2019","journal-title":"J. Crohn\u2019S. Colitis"},{"key":"10.1016\/j.phrs.2025.108059_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00551","article-title":"Inflammatory Bowel Disease: Genetics, Epigenetics, and Pathogenesis","volume":"6","author":"Loddo","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2025.108059_bib8","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.3748\/wjg.v26.i28.3998","article-title":"Secondary causes of inflammatory bowel diseases","volume":"26","author":"Ghouri","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.phrs.2025.108059_bib9","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1152\/physrev.00018.2018","article-title":"The Microbiota-Gut-Brain Axis","volume":"99","author":"Cryan","year":"2019","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.phrs.2025.108059_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23073464","article-title":"P. de. Dysbiosis in Inflammatory Bowel Disease: Pathogenic Role and Potential Therapeutic Targets","volume":"23","author":"Santana","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2025.108059_bib11","article-title":"Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases","volume":"10","author":"Parada Venegas","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2025.108059_bib12","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1053\/j.gastro.2011.02.016","article-title":"Pro-Inflammatory Cytokines in the Pathogenesis of IBD","volume":"140","author":"Strober","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phrs.2025.108059_bib13","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1136\/bmj.2.4947.1041","article-title":"Cortisone in Ulcerative Colitis","volume":"2","author":"Truelove","year":"1955","journal-title":"Br. Med J."},{"key":"10.1016\/j.phrs.2025.108059_bib14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-2036.2006.03156.x","article-title":"Review article: steroid resistance in inflammatory bowel disease \u2013 mechanisms and therapeutic strategies","volume":"25","author":"Creed","year":"2007","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.phrs.2025.108059_bib15","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2036.2006.03069.x","article-title":"Review article: mode of action and delivery of 5-aminosalicylic acid - new evidence","volume":"24","author":"Desreumaux","year":"2006","journal-title":"Aliment Pharm. Ther."},{"key":"10.1016\/j.phrs.2025.108059_bib16","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/1756283X11405250","article-title":"Optimizing clinical use of mesalazine (5-aminosalicylic acid) in inflammatory bowel disease","volume":"4","author":"Williams","year":"2011","journal-title":"Ther. Adv. Gastroenterol."},{"key":"10.1016\/j.phrs.2025.108059_bib17","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.3390\/ijms19082244","article-title":"Anti-TNF Therapy in Crohn\u2019s Disease","volume":"19","author":"Adegbola","year":"2018","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2025.108059_bib18","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1177\/2040622315586970","article-title":"Vedolizumab: an \u03b14\u03b27 integrin antagonist for ulcerative colitis and Crohn\u2019s disease","volume":"6","author":"Cherry","year":"2015","journal-title":"Ther. Adv. Chronic Dis."},{"key":"10.1016\/j.phrs.2025.108059_bib19","doi-asserted-by":"crossref","DOI":"10.1080\/00365521.2018.1447597","article-title":"Immunopathogenesis of inflammatory bowel disease and mechanisms of biological therapies","author":"Ahluwalia","year":"2018","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.phrs.2025.108059_bib20","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1136\/flgastro-2023-102400","article-title":"JAK inhibitors for inflammatory bowel disease: recent advances","volume":"15","author":"Honap","year":"2024","journal-title":"Frontline Gastroenterol."},{"key":"10.1016\/j.phrs.2025.108059_bib21","doi-asserted-by":"crossref","first-page":"871","DOI":"10.3390\/cancers15030871","article-title":"Risk of Cancer in Patients with Inflammatory Bowel Diseases and Keys for Patient Management","volume":"15","author":"Laredo","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.phrs.2025.108059_bib22","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.3748\/wjg.v17.i22.2723","article-title":"Comorbidity in inflammatory bowel disease","volume":"17","author":"Rom\u00e1n","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.phrs.2025.108059_bib23","article-title":"Treatment of Inflammatory Bowel Disease: A Comprehensive Review","volume":"8","author":"Cai","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.phrs.2025.108059_bib24","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/jhn.12787","article-title":"Adherence to exclusive enteral nutrition by adults with active Crohn\u2019s disease is associated with conscientiousness personality trait: a sub-study","volume":"33","author":"Wall","year":"2020","journal-title":"J. Hum. Nutr. Diet."},{"key":"10.1016\/j.phrs.2025.108059_bib25","doi-asserted-by":"crossref","first-page":"171","DOI":"10.5217\/ir.2018.00079","article-title":"An overview of the role of exclusive enteral nutrition for complicated Crohn\u2019s disease","volume":"17","author":"Adamji","year":"2019","journal-title":"Intest Res"},{"key":"10.1016\/j.phrs.2025.108059_bib26","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1093\/ecco-jcc\/jjad063","article-title":"Development and Validation of the Glasgow Exclusive Enteral Nutrition Index of Compliance","volume":"17","author":"Jatkowska","year":"2023","journal-title":"J. Crohn\u2019S. Colitis"},{"key":"10.1016\/j.phrs.2025.108059_bib27","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2147\/CEG.S267172","article-title":"Exclusive Enteral Nutrition in Adult Crohn\u2019s Disease: an Overview of Clinical Practice and Perceived Barriers","volume":"14","author":"de Sire","year":"2021","journal-title":"Clin. Exp. Gastroenterol."},{"key":"10.1016\/j.phrs.2025.108059_bib28","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.3748\/wjg.14.2678","article-title":"Surgery for inflammatory bowel disease","volume":"14","author":"Hwang","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.phrs.2025.108059_bib29","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrn3346","article-title":"Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour","volume":"13","author":"Cryan","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.phrs.2025.108059_bib30","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jcmgh.2018.04.003","article-title":"The Brain-Gut-Microbiome Axis","volume":"6","author":"Martin","year":"2018","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.phrs.2025.108059_bib31","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.coph.2019.08.001","article-title":"Small talk: microbial metabolites involved in the signaling from microbiota to brain","volume":"48","author":"Caspani","year":"2019","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.phrs.2025.108059_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00186","article-title":"Serotonin: A Potent Immune Cell Modulator in Autoimmune Diseases","volume":"11","author":"Wan","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2025.108059_bib33","doi-asserted-by":"crossref","first-page":"2","DOI":"10.12965\/jer.2040016.008","article-title":"The role of neuroinflammation on pathogenesis of affective disorders","volume":"16","author":"Rhie","year":"2020","journal-title":"J. Exerc. Rehabil."},{"key":"10.1016\/j.phrs.2025.108059_bib34","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/apt.14226","article-title":"Review article: the many potential roles of intestinal serotonin (5-hydroxytryptamine, 5-HT) signalling in inflammatory bowel disease","volume":"46","author":"Coates","year":"2017","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2025.108059_bib35","doi-asserted-by":"crossref","first-page":"177","DOI":"10.31887\/DCNS.2000.2.3\/pschulz","article-title":"Psychotropic medication, psychiatric disorders, and higher brain functions","volume":"2","author":"Schulz","year":"2000","journal-title":"Dialog. Clin. Neurosci."},{"key":"10.1016\/j.phrs.2025.108059_bib36","doi-asserted-by":"crossref","first-page":"8870","DOI":"10.3390\/ijms22168870","article-title":"The Gut-Brain Axis in Inflammatory Bowel Disease\u2014Current and Future Perspectives","volume":"22","author":"G\u00fcnther","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2025.108059_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2018.00049","article-title":"The Vagus Nerve at the Interface of the Microbiota-Gut-Brain Axis","volume":"12","author":"Bonaz","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.phrs.2025.108059_bib38","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2165\/00023210-199810060-00005","article-title":"Selective Serotonin Reuptake Inhibitor-Induced Disturbances of Haemostasis","volume":"10","author":"Berk","year":"1998","journal-title":"CNS Drugs"},{"key":"10.1016\/j.phrs.2025.108059_bib39","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0091-7435(03)00123-3","article-title":"The impact of adverse childhood experiences on health problems: evidence from four birth cohorts dating back to 1900","volume":"37","author":"Dube","year":"2003","journal-title":"Prev. Med"},{"key":"10.1016\/j.phrs.2025.108059_bib40","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/PSY.0b013e3181907888","article-title":"Cumulative Childhood Stress and Autoimmune Diseases in Adults","volume":"71","author":"Dube","year":"2009","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.phrs.2025.108059_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.chiabu.2021.105322","article-title":"Childhood trauma, dissociation, alexithymia, and anger in people with autoimmune diseases: A mediation model","volume":"122","author":"Macarenco","year":"2021","journal-title":"Child Abus. Negl."},{"key":"10.1016\/j.phrs.2025.108059_bib42","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1177\/13591053231173918","article-title":"The burden of early life stress in chronic inflammatory bowel diseases","volume":"28","author":"Minjoz","year":"2023","journal-title":"J. Health Psychol."},{"key":"10.1016\/j.phrs.2025.108059_bib43","first-page":"1127","article-title":"Adverse Childhood Events, Post-Traumatic Stress Disorder, Infectious Encephalopathies and Immune-Mediated Disease","volume":"10","author":"Bransfield","year":"2022","journal-title":"Healthc. (Basel)"},{"key":"10.1016\/j.phrs.2025.108059_bib44","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/jcag\/gwad026","article-title":"Differentiating Childhood Traumas in Inflammatory Bowel Disease","volume":"6","author":"Gnat","year":"2023","journal-title":"J. Can. Assoc. Gastroenterol."},{"key":"10.1016\/j.phrs.2025.108059_bib45","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1136\/gutjnl-2018-317182","article-title":"Depression increases the risk of inflammatory bowel disease, which may be mitigated by the use of antidepressants in the treatment of depression","volume":"68","author":"Frolkis","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.phrs.2025.108059_bib46","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1504\/IJBHR.2011.043414","article-title":"Measuring bias in self-reported data","volume":"2","author":"Rosenman","year":"2011","journal-title":"Int J. Behav. Health Res"},{"key":"10.1016\/j.phrs.2025.108059_bib47","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1093\/ibd\/izy367","article-title":"The Influence of Antidepressants on the Disease Course Among Patients With Crohn\u2019s Disease and Ulcerative Colitis\u2014A Danish Nationwide Register\u2013Based Cohort Study","volume":"25","author":"Kristensen","year":"2019","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.phrs.2025.108059_bib48","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/ibd.21846","article-title":"Do Antidepressants Influence the Disease Course in Inflammatory Bowel Disease? A Retrospective Case-Matched Observational Study","volume":"18","author":"Goodhand","year":"2012","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.phrs.2025.108059_bib49","doi-asserted-by":"crossref","first-page":"595","DOI":"10.4103\/1735-1995.165969","article-title":"Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: A double-blind controlled study","volume":"20","author":"Daghaghzadeh","year":"2015","journal-title":"J. Res Med Sci."},{"key":"10.1016\/j.phrs.2025.108059_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.604179","article-title":"The Gut-Brain Axis: How Microbiota and Host Inflammasome Influence Brain Physiology and Pathology","volume":"11","author":"Rutsch","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2025.108059_bib51","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1177\/1535370219891690","article-title":"The microbiota-gut-brain axis: An emerging role for the epigenome","volume":"245","author":"Louwies","year":"2020","journal-title":"Exp. Biol. Med (Maywood)"},{"key":"10.1016\/j.phrs.2025.108059_bib52","doi-asserted-by":"crossref","first-page":"28","DOI":"10.5056\/jnm.2011.17.1.28","article-title":"Basic and Translational Understandings of Microbial Recognition by Toll-Like Receptors in the Intestine","volume":"17","author":"Rhee","year":"2011","journal-title":"J. Neurogastroenterol. Motil."},{"key":"10.1016\/j.phrs.2025.108059_bib53","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/19490976.2019.1629235","article-title":"Lipopolysaccharides modulate intestinal epithelial permeability and inflammation in a species-specific manner","volume":"11","author":"Stephens","year":"2019","journal-title":"Gut Microbes"},{"key":"10.1016\/j.phrs.2025.108059_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2024.138739","article-title":"Dietary polyphenols regulate appetite mechanism via gut-brain axis and gut homeostasis","volume":"446","author":"Liu","year":"2024","journal-title":"Food Chem."},{"key":"10.1016\/j.phrs.2025.108059_bib55","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.7502","article-title":"Factors affecting the composition of the gut microbiota, and its modulation","volume":"7","author":"Hasan","year":"2019","journal-title":"PeerJ"},{"key":"10.1016\/j.phrs.2025.108059_bib56","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/nn.4030","article-title":"Host microbiota constantly control maturation and function of microglia in the CNS","volume":"18","author":"Erny","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.phrs.2025.108059_bib57","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/jcbfm.2012.153","article-title":"Immunologic privilege in the central nervous system and the blood\u2013brain barrier","volume":"33","author":"Muldoon","year":"2013","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.phrs.2025.108059_bib58","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009759","article-title":"The gut microbiota influences blood-brain barrier permeability in mice","volume":"6","author":"Braniste","year":"2014","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.phrs.2025.108059_bib59","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S2468-1253(21)00014-5","article-title":"Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis","volume":"6","author":"Barberio","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.phrs.2025.108059_bib60","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jad.2019.12.020","article-title":"The gut microbiota is associated with psychiatric symptom severity and treatment outcome among individuals with serious mental illness","volume":"264","author":"Madan","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.phrs.2025.108059_bib61","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s40168-023-01635-6","article-title":"Multi-omics reveal microbial determinants impacting the treatment outcome of antidepressants in major depressive disorder","volume":"11","author":"Wang","year":"2023","journal-title":"Microbiome"},{"key":"10.1016\/j.phrs.2025.108059_bib62","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1186\/1742-2094-10-43","article-title":"Neuroinflammation and psychiatric illness","volume":"10","author":"Najjar","year":"2013","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.phrs.2025.108059_bib63","first-page":"1003","article-title":"Neuroinflammation Induces Neurodegeneration","volume":"1","author":"Kempuraj","year":"2016","journal-title":"J. Neurol. Neurosurg. Spine"},{"key":"10.1016\/j.phrs.2025.108059_bib64","doi-asserted-by":"crossref","first-page":"45S","DOI":"10.2967\/jnumed.121.263200","article-title":"Imaging Neuroinflammation in Neurodegenerative Disorders","volume":"63","author":"Masdeu","year":"2022","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.phrs.2025.108059_bib65","series-title":"Emerging Neurobiology of Antidepressant Treatments","first-page":"217","article-title":"Anti-inflammatory Drugs in the Treatment of Depression","author":"Cavanagh","year":"2024"},{"key":"10.1016\/j.phrs.2025.108059_bib66","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/gutjnl-2017-315666","article-title":"Inflammatory bowel disease increases the risk of Parkinson\u2019s disease: a Danish nationwide cohort study 1977\u20132014","volume":"68","author":"Villumsen","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.phrs.2025.108059_bib67","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1136\/gutjnl-2020-320789","article-title":"Inflammatory bowel disease is associated with higher dementia risk: a nationwide longitudinal study","volume":"70","author":"Zhang","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.phrs.2025.108059_bib68","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ajpath.2021.09.006","article-title":"Chronic Intestinal Inflammation Suppresses Brain Activity by Inducing Neuroinflammation in Mice","volume":"192","author":"Mitchell","year":"2022","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.phrs.2025.108059_bib69","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.bbi.2023.03.001","article-title":"Hippocampal GFAP-positive astrocyte responses to amyloid and tau pathologies","volume":"110","author":"De Bastiani","year":"2023","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.phrs.2025.108059_bib70","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.3390\/cells12091309","article-title":"GFAP as a Potential Biomarker for Alzheimer\u2019s Disease: A Systematic Review and Meta-Analysis","volume":"12","author":"Kim","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2025.108059_bib71","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1038\/s41380-023-02071-6","article-title":"Gut microbiota changes require vagus nerve integrity to promote depressive-like behaviors in mice","volume":"28","author":"Siopi","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.phrs.2025.108059_bib72","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3389\/fncel.2019.00363","article-title":"Brain-Derived Neurotrophic Factor: A Key Molecule for Memory in the Healthy and the Pathological Brain","volume":"13","author":"Miranda","year":"2019","journal-title":"Front Cell Neurosci."},{"key":"10.1016\/j.phrs.2025.108059_bib73","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1053\/j.gastro.2011.04.052","article-title":"The Intestinal Microbiota Affect Central Levels of Brain-Derived Neurotropic Factor and Behavior in Mice","volume":"141","author":"Bercik","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phrs.2025.108059_bib74","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.clinph.2018.02.127","article-title":"Electroencephalographic correlates of low-frequency vagus nerve stimulation therapy for Crohn\u2019s disease","volume":"129","author":"Kibleur","year":"2018","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.phrs.2025.108059_bib75","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neubiorev.2013.05.007","article-title":"Interpreting EEG alpha activity","volume":"44","author":"Bazanova","year":"2014","journal-title":"Neurosci. Biobehav Rev."},{"key":"10.1016\/j.phrs.2025.108059_bib76","series-title":"Microbial Endocrinology: The Microbiota-Gut-Brain Axis in Health and Disease","first-page":"39","article-title":"The Enteric Nervous System and Gastrointestinal Innervation: Integrated Local and Central Control","author":"Furness","year":"2014"},{"key":"10.1016\/j.phrs.2025.108059_bib77","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/jcag\/gwy039","article-title":"Characterization of Serotonin Signaling Components in Patients with Inflammatory Bowel Disease","volume":"2","author":"Shajib","year":"2019","journal-title":"J. Can. Assoc. Gastroenterol."},{"key":"10.1016\/j.phrs.2025.108059_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2023.578155","article-title":"Platelets bridging the gap between gut dysbiosis and neuroinflammation in stress-linked disorders: A narrative review","volume":"382","author":"Rust","year":"2023","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.phrs.2025.108059_bib79","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1046\/j.1471-4159.1996.66062621.x","article-title":"Allelic Variation of Human Serotonin Transporter Gene Expression","volume":"66","author":"Heils","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phrs.2025.108059_bib80","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1126\/science.274.5292.1527","article-title":"Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region","volume":"274","author":"Lesch","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.phrs.2025.108059_bib81","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2013.80","article-title":"Genotyping serotonin transporter polymorphisms 5-HTTLPR and rs25531 in European- and African-American subjects from the National Institute of Mental Health\u2019s Collaborative Center for Genomic Studies","volume":"3","author":"Odgerel","year":"2013","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.phrs.2025.108059_bib82","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s10620-014-3482-y","article-title":"Association of Serotonin Transporter Promoter Polymorphism (5-HTTLPR) with Microscopic Colitis and Ulcerative Colitis","volume":"60","author":"Sikander","year":"2015","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.phrs.2025.108059_bib83","first-page":"228","article-title":"5-hydroxytryptamine and platelet aggregation","volume":"42","author":"De Clerck","year":"1983","journal-title":"Fed. Proc."},{"key":"10.1016\/j.phrs.2025.108059_bib84","unstructured":"Raote, I., Bhattacharya, A. & Panicker, M.M. Serotonin 2A (5-HT2A) Receptor Function: Ligand-Dependent Mechanisms and Pathways. in Serotonin Receptors in Neurobiology (ed. Chattopadhyay, A.) (CRC Press\/Taylor & Francis, Boca Raton (FL), 2007)."},{"key":"10.1016\/j.phrs.2025.108059_bib85","doi-asserted-by":"crossref","first-page":"13863","DOI":"10.3748\/wjg.v20.i38.13863","article-title":"Inflammatory bowel disease and thromboembolism","volume":"20","author":"Zezos","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.phrs.2025.108059_bib86","doi-asserted-by":"crossref","first-page":"8817","DOI":"10.3390\/ijms21228817","article-title":"Beyond Haemostasis and Thrombosis: Platelets in Depression and Its Co-Morbidities","volume":"21","author":"Izzi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2025.108059_bib87","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/j.1538-7836.2009.03476.x","article-title":"Serotonin stimulates platelet receptor shedding by tumor necrosis factor-alpha-converting enzyme (ADAM17)","volume":"7","author":"Duerschmied","year":"2009","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.phrs.2025.108059_bib88","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/ibd\/izaa208","article-title":"Serum Serotonin Differentiates Between Disease Activity States in Crohn\u2019s Patients","volume":"26","author":"Manzella","year":"2020","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.phrs.2025.108059_bib89","doi-asserted-by":"crossref","first-page":"G761","DOI":"10.1152\/ajpgi.00244.2020","article-title":"The serotonin reuptake transporter is reduced in the epithelium of active Crohn\u2019s disease and ulcerative colitis","volume":"319","author":"J\u00f8randli","year":"2020","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.phrs.2025.108059_bib90","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.cell.2015.02.047","article-title":"Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis","volume":"161","author":"Yano","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2025.108059_bib91","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.3390\/nu15102275","article-title":"Gut Microbial Metabolite Butyrate and Its Therapeutic Role in Inflammatory Bowel Disease: A Literature Review","volume":"15","author":"Recharla","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.phrs.2025.108059_bib92","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1481496","article-title":"Microscopic messengers: microbiota-derived bacterial extracellular vesicles in inflammatory bowel disease","volume":"15","author":"Zubair","year":"2024","journal-title":"Front Microbiol"},{"key":"10.1016\/j.phrs.2025.108059_bib93","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1096\/fj.14-259598","article-title":"Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells","volume":"29","author":"Reigstad","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.phrs.2025.108059_bib94","doi-asserted-by":"crossref","first-page":"R1269","DOI":"10.1152\/ajpregu.00442.2002","article-title":"Short-chain fatty acids stimulate colonic transit via intraluminal 5-HT release in rats","volume":"284","author":"Fukumoto","year":"2003","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.phrs.2025.108059_bib95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12876-022-02191-3","article-title":"Characterization of short-chain fatty acids in patients with ulcerative colitis: a meta-analysis","volume":"22","author":"Xu","year":"2022","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.phrs.2025.108059_bib96","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.733992","article-title":"The Gut Microbiota in Inflammatory Bowel Disease","volume":"12","author":"Qiu","year":"2022","journal-title":"Front. Cell. Infect. Microbiol"},{"key":"10.1016\/j.phrs.2025.108059_bib97","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12161","article-title":"Microbiota-derived extracellular vesicles in interkingdom communication in the gut","volume":"10","author":"D\u00edaz-Garrido","year":"2021","journal-title":"J. Extracell. Vesicles"},{"issue":"20","key":"10.1016\/j.phrs.2025.108059_bib98","first-page":"15","article-title":"Caco-2 Cells as a Model for Intestinal Absorption","volume":"47","author":"Angelis","year":"2011","journal-title":"Curr. Protoc. Toxicol."},{"key":"10.1016\/j.phrs.2025.108059_bib99","article-title":"The clinical effects of probiotics for inflammatory bowel disease","volume":"97","author":"Jia","year":"2018","journal-title":"Med. (Baltim. )"},{"key":"10.1016\/j.phrs.2025.108059_bib100","doi-asserted-by":"crossref","first-page":"5338","DOI":"10.3390\/ijms25105338","article-title":"Modulation of Serotonin-Related Genes by Extracellular Vesicles of the Probiotic Escherichia coli Nissle 1917 in the Interleukin-1\u03b2-Induced Inflammation Model of Intestinal Epithelial Cells","volume":"25","author":"Olivo-Mart\u00ednez","year":"2024","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2025.108059_bib101","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3389\/fncel.2017.00222","article-title":"Serotonin Transporter Genotype Modulates the Gut Microbiota Composition in Young Rats, an Effect Augmented by Early Life Stress","volume":"11","author":"El Aidy","year":"2017","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.phrs.2025.108059_bib102","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3390\/pathogens8030126","article-title":"Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome","volume":"8","author":"Khan","year":"2019","journal-title":"Pathogens"},{"key":"10.1016\/j.phrs.2025.108059_bib103","doi-asserted-by":"crossref","first-page":"20586","DOI":"10.1038\/s41598-022-24901-3","article-title":"Chronic gut inflammation impairs contextual control of fear","volume":"12","author":"Matisz","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2025.108059_bib104","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1053\/j.gastro.2009.08.041","article-title":"Serotonin Has a Key Role in Pathogenesis of Experimental Colitis","volume":"137","author":"Ghia","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phrs.2025.108059_bib105","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.ajpath.2010.10.028","article-title":"Serotonin Activates Dendritic Cell Function in the Context of Gut Inflammation","volume":"178","author":"Li","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.phrs.2025.108059_bib106","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2982.2008.01210.x","article-title":"IL1\u03b2- and LPS-induced serotonin secretion is increased in EC cells derived from Crohn\u2019s disease","volume":"21","author":"Kidd","year":"2009","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.phrs.2025.108059_bib107","series-title":"StatPearls","article-title":"Selective Serotonin Reuptake Inhibitors","author":"Chu","year":"2024"},{"key":"10.1016\/j.phrs.2025.108059_bib108","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jad.2023.02.143","article-title":"Association analysis of gut microbiota and efficacy of SSRIs antidepressants in patients with major depressive disorder","volume":"330","author":"Gao","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.phrs.2025.108059_bib109","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s12974-015-0434-1","article-title":"Lipopolysaccharide-induced blood-brain barrier disruption: roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit","volume":"12","author":"Banks","year":"2015","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.phrs.2025.108059_bib110","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00210-010-0535-4","article-title":"Moclobemide exerts anti-inflammatory effect in lipopolysaccharide-activated primary mixed glial cell culture","volume":"382","author":"Bielecka","year":"2010","journal-title":"NaunynSchmied. Arch. Pharm."},{"key":"10.1016\/j.phrs.2025.108059_bib111","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2147\/JIR.S140188","article-title":"Mechanisms of NF-\u03baB p65 and strategies for therapeutic manipulation","volume":"11","author":"Giridharan","year":"2018","journal-title":"J. Inflamm. Res"},{"key":"10.1016\/j.phrs.2025.108059_bib112","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.bbi.2011.12.011","article-title":"A comparative examination of the anti-inflammatory effects of SSRI and SNRI antidepressants on LPS stimulated microglia","volume":"26","author":"Tynan","year":"2012","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.phrs.2025.108059_bib113","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1465-9921-8-35","article-title":"Anti-inflammatory properties of desipramine and fluoxetine","volume":"8","author":"Roumestan","year":"2007","journal-title":"Respir. Res."},{"key":"10.1016\/j.phrs.2025.108059_bib114","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3390\/neurolint15010009","article-title":"Inflammation and Treatment-Resistant Depression from Clinical to Animal Study: A Possible Link?","volume":"15","author":"Almutabagani","year":"2023","journal-title":"Neurol. Int"},{"key":"10.1016\/j.phrs.2025.108059_bib115","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00358","article-title":"Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities","volume":"6","author":"Szabo","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2025.108059_bib116","series-title":"Neuroplasticity. in StatPearls","author":"Puderbaugh","year":"2024"},{"key":"10.1016\/j.phrs.2025.108059_bib117","doi-asserted-by":"crossref","first-page":"4245821","DOI":"10.1155\/2020\/4245821","article-title":"Neuroplasticity in the Pathology of Neurodegenerative Diseases","volume":"2020","author":"Dorszewska","year":"2020","journal-title":"Neural Plast."},{"key":"10.1016\/j.phrs.2025.108059_bib118","doi-asserted-by":"crossref","first-page":"11708","DOI":"10.3390\/ijms252111708","article-title":"The Role of Neuroinflammation in Shaping Neuroplasticity and Recovery Outcomes Following Traumatic Brain Injury: A Systematic Review","volume":"25","author":"Calderone","year":"2024","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2025.108059_bib119","doi-asserted-by":"crossref","first-page":"237","DOI":"10.5483\/BMBRep.2017.50.5.038","article-title":"Synapses in neurodegenerative diseases","volume":"50","author":"Bae","year":"2017","journal-title":"BMB Rep."},{"key":"10.1016\/j.phrs.2025.108059_bib120","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/6871089","article-title":"The Role of Neural Plasticity in Depression: From Hippocampus to Prefrontal Cortex","volume":"2017","author":"Liu","year":"2017","journal-title":"Neural Plast."},{"key":"10.1016\/j.phrs.2025.108059_bib121","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.3390\/pharmaceutics15082052","article-title":"Therapeutic Strategies Aimed at Improving Neuroplasticity in Alzheimer Disease","volume":"15","author":"Colavitta","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.phrs.2025.108059_bib122","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5483\/BMBRep.2017.50.1.131","article-title":"The cellular basis of dendrite pathology in neurodegenerative diseases","volume":"50","author":"Kweon","year":"2017","journal-title":"BMB Rep."},{"key":"10.1016\/j.phrs.2025.108059_bib123","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/247150","article-title":"Synapses and Dendritic Spines as Pathogenic Targets in Alzheimer\u2019s Disease","author":"Yu","year":"2012","journal-title":"Neural Plast. 2012"},{"key":"10.1016\/j.phrs.2025.108059_bib124","first-page":"473","article-title":"Chapter 31 - Alzheimer disease and neuroplasticity","volume":"184","author":"Koch","year":"2022"},{"key":"10.1016\/j.phrs.2025.108059_bib125","doi-asserted-by":"crossref","first-page":"G853","DOI":"10.1152\/ajpgi.00206.2019","article-title":"Enteric neuroplasticity and dysmotility in inflammatory disease: key players and possible therapeutic targets","volume":"317","author":"Spear","year":"2019","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.phrs.2025.108059_bib126","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","article-title":"Psychedelics Promote Structural and Functional Neural Plasticity","volume":"23","author":"Ly","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.phrs.2025.108059_bib127","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2014.00430","article-title":"Brain-derived neurotrophic factor: a bridge between inflammation and neuroplasticity","volume":"8","author":"Calabrese","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.phrs.2025.108059_bib128","doi-asserted-by":"crossref","first-page":"77","DOI":"10.5498\/wjp.v12.i1.77","article-title":"Brain-derived neurotrophic factor and inflammation in depression: Pathogenic partners in crime?","volume":"12","author":"Porter","year":"2022","journal-title":"World J. Psychiatry"},{"key":"10.1016\/j.phrs.2025.108059_bib129","doi-asserted-by":"crossref","first-page":"10312","DOI":"10.1038\/s41598-025-95546-1","article-title":"Deciphering genetic causality between plasma BDNF and 91 circulating inflammatory proteins through bidirectional mendelian randomization","volume":"15","author":"Sun","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2025.108059_bib130","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1523\/JNEUROSCI.17-08-02785.1997","article-title":"5-HT2A Receptor-Mediated Regulation of Brain-Derived Neurotrophic Factor mRNA in the Hippocampus and the Neocortex","volume":"17","author":"Vaidya","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2025.108059_bib131","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1124\/jpet.108.143461","article-title":"Serotonin 5-Hydroxytryptamine2A Receptor Activation Suppresses Tumor Necrosis Factor-\u03b1-Induced Inflammation with Extraordinary Potency","volume":"327","author":"Yu","year":"2008","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.phrs.2025.108059_bib132","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1476-5381.1995.tb13307.x","article-title":"The interaction of antidepressant drugs with central and peripheral (enteric) 5-HT3 and 5-HT4 receptors","volume":"114","author":"Lucchelli","year":"1995","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.phrs.2025.108059_bib133","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/rheumatology\/keh627","article-title":"Pharmacokinetic\u2013pharmacodynamic correlations and biomarkers in the development of COX-2 inhibitors","volume":"44","author":"Huntjens","year":"2005","journal-title":"Rheumatology"},{"key":"10.1016\/j.phrs.2025.108059_bib134","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.2147\/JIR.S317182","article-title":"Anti-Inflammatory Effects of Four Psilocybin-Containing Magic Mushroom Water Extracts in vitro on 15-Lipoxygenase Activity and on Lipopolysaccharide-Induced Cyclooxygenase-2 and Inflammatory Cytokines in Human U937 Macrophage Cells","volume":"14","author":"Nkadimeng","year":"2021","journal-title":"J. Inflamm. Res"},{"key":"10.1016\/j.phrs.2025.108059_bib135","doi-asserted-by":"crossref","first-page":"6743","DOI":"10.3390\/cimb45080427","article-title":"Anti-Inflammatory Effects of Serotonin Receptor and Transient Receptor Potential Channel Ligands in Human Small Intestinal Epithelial Cells","volume":"45","author":"Robinson","year":"2023","journal-title":"CIMB"},{"key":"10.1016\/j.phrs.2025.108059_bib136","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.3390\/molecules28062624","article-title":"The Effect of Combined Treatment of Psilocybin and Eugenol on Lipopolysaccharide-Induced Brain Inflammation in Mice","volume":"28","author":"Zanikov","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.phrs.2025.108059_bib137","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1181973","article-title":"Lipopolysaccharide-induced depression-like model in mice: meta-analysis and systematic evaluation","volume":"14","author":"Yin","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2025.108059_bib138","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.phrs.2025.108059_bib139","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.biopsych.2022.08.025","article-title":"Lysergic Acid Diethylamide\u2013Assisted Therapy in Patients With Anxiety With and Without a Life-Threatening Illness: A Randomized, Double-Blind, Placebo-Controlled Phase II Study","volume":"93","author":"Holze","year":"2023","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2025.108059_bib140","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s13643-022-02107-y","article-title":"Effective maNagement of depression among patients witH cANCEr (ENHANCE): a protocol for a hybrid systematic review and network meta-analysis of randomised controlled trials of interventions for depressive symptoms","volume":"11","author":"Pertl","year":"2022","journal-title":"Syst. Rev."},{"key":"10.1016\/j.phrs.2025.108059_bib141","first-page":"164","article-title":"Considering the Bidirectional Pathways Between Depression and IBD: Recommendations for Comprehensive IBD Care","volume":"13","author":"Keefer","year":"2017","journal-title":"Gastroenterol. Hepatol. (N. Y)"},{"key":"10.1016\/j.phrs.2025.108059_bib142","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/sj.bjc.6602949","article-title":"The effectiveness of treatment for depression\/depressive symptoms in adults with cancer: a systematic review - PMC","volume":"94","author":"Williams","year":"2006","journal-title":"BJC"},{"key":"10.1016\/j.phrs.2025.108059_bib143","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.bbi.2025.03.002","article-title":"Immune dysregulation in psychiatric disorders with and without exposure to childhood maltreatment: A transdiagnostic stratified meta-analysis","volume":"127","author":"Den Noortgate","year":"2025","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.phrs.2025.108059_bib144","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41568-021-00347-z","article-title":"Systemic immunity in cancer","volume":"21","author":"Hiam-Galvez","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.phrs.2025.108059_bib145","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1093\/ecco-jcc\/jjab085","article-title":"Immunological Networks Defining the Heterogeneity of Inflammatory Bowel Diseases","volume":"15","author":"Selin","year":"2021","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.phrs.2025.108059_bib146","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1177\/0269881115609019","article-title":"Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin","volume":"29","author":"Barrett","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.phrs.2025.108059_bib147","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2174\/1874473708666150107121331","article-title":"Psilocybin-occasioned Mystical Experiences in the Treatment of Tobacco Addiction","volume":"7","author":"Garcia-Romeu","year":"2015","journal-title":"Curr. Drug Abus. Rev."},{"key":"10.1016\/j.phrs.2025.108059_bib148","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/s41386-022-01297-2","article-title":"Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects","volume":"47","author":"Holze","year":"2022","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.phrs.2025.108059_bib149","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.841648","article-title":"Psilocybin-Induced Mystical-Type Experiences are Related to Persisting Positive Effects: A Quantitative and Qualitative Report","volume":"13","author":"McCulloch","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2025.108059_bib150","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s11845-021-02668-2","article-title":"Psychedelic perceptions: mental health service user attitudes to psilocybin therapy","volume":"191","author":"Corrigan","year":"2022","journal-title":"Ir. J. Med Sci."},{"key":"10.1016\/j.phrs.2025.108059_bib151","doi-asserted-by":"crossref","DOI":"10.1016\/j.xjmad.2023.100023","article-title":"Perceptions of psychedelic-assisted therapy among Black Americans","volume":"4","author":"Carter","year":"2023","journal-title":"J. Mood Anxiety Disord."},{"key":"10.1016\/j.phrs.2025.108059_bib152","doi-asserted-by":"crossref","first-page":"e3356","DOI":"10.1093\/milmed\/usac400","article-title":"Beliefs and Perceived Barriers Regarding Psychedelic-assisted Therapy in a Pilot Study of Service Members and Veterans With a History of Traumatic Brain Injury","volume":"188","author":"Gray","year":"2023","journal-title":"Mil. Med."},{"key":"10.1016\/j.phrs.2025.108059_bib153","doi-asserted-by":"crossref","first-page":"1190507","DOI":"10.3389\/fpsyt.2023.1190507","article-title":"Medical student attitudes and perceptions of psychedelic-assisted therapies","volume":"14","author":"Li","year":"2023","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.phrs.2025.108059_bib154","doi-asserted-by":"crossref","DOI":"10.1503\/cmaj.160991","article-title":"Antidepressant discontinuation syndrome","volume":"189","author":"Gabriel","year":"2017","journal-title":"CMAJ"},{"key":"10.1016\/j.phrs.2025.108059_bib155","series-title":"StatPearls","article-title":"Serotonin Syndrome","author":"Simon","year":"2024"},{"key":"10.1016\/j.phrs.2025.108059_bib156","first-page":"19","article-title":"The Timing of Antidepressant Effects: A Comparison of Diverse Pharmacological and Somatic Treatments","volume":"3","author":"Machado-Vieira","year":"2010","journal-title":"Pharm. (Basel)"},{"key":"10.1016\/j.phrs.2025.108059_bib157","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2147\/NDT.S198774","article-title":"Management of Treatment-Resistant Depression: Challenges and Strategies","volume":"16","author":"Voineskos","year":"2020","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.phrs.2025.108059_bib158","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1556\/2054.2022.00203","article-title":"Changing attitudes to psychedelic drug assisted therapy: The induction of empathy to enhance community support for innovative interventions in mental health","volume":"6","author":"Botansky","year":"2022","journal-title":"J. Psychedelic Stud."},{"key":"10.1016\/j.phrs.2025.108059_bib159","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1123424","article-title":"Exploring psilocybin-assisted psychotherapy in the treatment of methamphetamine use disorder","volume":"14","author":"Brett","year":"2023","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.phrs.2025.108059_bib160","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jad.2024.02.089","article-title":"Predicting the outcome of psilocybin treatment for depression from baseline fMRI functional connectivity","volume":"353","author":"Copa","year":"2024","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.phrs.2025.108059_bib161","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41386-023-01666-5","article-title":"Therapeutic mechanisms of psychedelics and entactogens","volume":"49","author":"Heifets","year":"2024","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.phrs.2025.108059_bib162","unstructured":"Johns Hopkins Medicine Receives First Federal Grant for Psychedelic Treatment Research in 50 years. \u3008https:\/\/www.hopkinsmedicine.org\/news\/newsroom\/news-releases\/2021\/10\/johns-hopkins-medicine-receives-first-federal-grant-for-psychedelic-treatment-research-in-50-years\u3009."},{"key":"10.1016\/j.phrs.2025.108059_bib163","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107338","article-title":"Mind over matter: the microbial mindscapes of psychedelics and the gut-brain axis","volume":"207","author":"Caspani","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2025.108059_bib164","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1007\/s00213-021-05876-x","article-title":"Serotonin toxicity of serotonergic psychedelics","volume":"239","author":"Malcolm","year":"2022","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.phrs.2025.108059_bib165","doi-asserted-by":"crossref","first-page":"317","DOI":"10.5946\/ce.2013.46.4.317","article-title":"The Role of Colonoscopy in Inflammatory Bowel Disease","volume":"46","author":"Kim","year":"2013","journal-title":"Clin. Endosc."},{"key":"10.1016\/j.phrs.2025.108059_bib166","first-page":"77","article-title":"Faecal Calprotectin","volume":"39","author":"Pathirana","year":"2018","journal-title":"Clin. Biochem Rev."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825004840?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825004840?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T23:55:26Z","timestamp":1766188526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661825004840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":166,"alternative-id":["S1043661825004840"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2025.108059","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From the gut to the brain: Potential novel avenues for IBD treatment via serotonergic pathways","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2025.108059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108059"}}